# SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting Coronary Stent System

> **NCT00180453** · PHASE3 · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 60 (actual)

## Conditions studied

- Coronary Artery Disease
- Everolimus
- Vascular Disease
- Myocardial Ischemia
- Coronary Artery Stenosis

## Interventions

- **DEVICE:** Coronary artery drug eluting stent placement
- **DEVICE:** Coronary artery stent placement

## Key facts

- **NCT ID:** NCT00180453
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** 2005-04
- **Final completion:** 2009-06
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2010-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00180453

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00180453, "SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting Coronary Stent System". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00180453. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*